Snowden Capital Advisors LLC Has $2.86 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Snowden Capital Advisors LLC lessened its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 73.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,818 shares of the biotechnology company's stock after selling 13,627 shares during the period. Snowden Capital Advisors LLC's holdings in Axon Enterprise were worth $2,863,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of AXON. Capital World Investors lifted its holdings in Axon Enterprise by 86.4% during the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after buying an additional 841,772 shares during the last quarter. Alliancebernstein L.P. raised its stake in Axon Enterprise by 273.8% during the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after acquiring an additional 812,337 shares in the last quarter. Norges Bank bought a new stake in Axon Enterprise during the 4th quarter valued at $482,081,000. GQG Partners LLC acquired a new position in shares of Axon Enterprise during the 4th quarter valued at $478,349,000. Finally, Vanguard Group Inc. increased its position in shares of Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the period. Institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In other news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Brittany Bagley sold 3,400 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $700.00, for a total value of $2,380,000.00. Following the sale, the chief financial officer now owns 131,833 shares in the company, valued at approximately $92,283,100. This represents a 2.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 25,064 shares of company stock valued at $15,817,127 over the last quarter. Insiders own 4.40% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on AXON shares. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Needham & Company LLC lifted their target price on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and an average target price of $652.73.

Axon Enterprise Stock Up 0.1%

Shares of AXON traded up $0.43 during midday trading on Tuesday, reaching $742.75. 383,468 shares of the stock were exchanged, compared to its average volume of 751,632. The firm has a 50 day simple moving average of $588.30 and a 200-day simple moving average of $597.92. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $744.51. The company has a market cap of $57.82 billion, a price-to-earnings ratio of 191.93, a P/E/G ratio of 5.17 and a beta of 1.24. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The company had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. During the same quarter in the previous year, the firm earned $1.15 earnings per share. The business's quarterly revenue was up 31.3% compared to the same quarter last year. Research analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.